generics
-
News
The Chinese pharmaceutical market ranks second in the world after the United States
According to data recently collected by the health information company IQVIA, China has reached the second position as the…
Leggi » -
News
generics. Veneto TAR agrees with the Region "for technical reasons"
REJECTED BY VENETO TAR APPEAL AGAINST VENETO REGION AND ZERO COMPANY FOR AWARD OF EQUIVALENT DRUG FOR HIV TREATMENT "The failure…
Leggi » -
News
Piedmont, Cossolo (Federfarma) on medicines by bike at home: "Under these conditions"
Piedmont, Cossolo on medicines by bike at home: "Under these conditions" 12/04/2018 - Federfarma Federfarma takes action on the case of…
Leggi » -
News
China launches package of rules to protect generic drugs
The Chinese government has issued a new package of provisions, including tax breaks, to promote generic medicines. The whole…
Leggi » -
First floor
EMA recommends the suspension of 300 generics. Unreliable
EMA recommends suspension of drugs due to unreliable studies by Micro Therapeutic Research Labs The drugs in…
Leggi » -
News
Häusermann (Assogenerici): “Grateful to the pharmacists for spreading the culture of generics”. Ed
The equivalent drug industry recognizes a great merit to pharmacies, namely that of having 'educated' the…
Leggi » -
News
Assogenerics. "Pure" generics absorb 21.5% in units and 12.4% in pharmacy channel values
Another year of growth for the generic drug market which in 2017 absorbed 21.5% per pack…
Leggi » -
News
Agreement on regional autonomy. Decisions based on the therapeutic equivalence of medicines are expected to be taken
Autonomy agreements for Veneto, Lombardy and Emilia: requests on equivalents and direct distribution 02/03/2018 – Federfarma Signed at Palazzo…
Leggi » -
News
USA. Generic drug costs 28 times more than the patented one
Il medicinale è usato per la malattia di Wilson NEW YORK – Anche i farmaci generici possono avere costi spropositati.…
Leggi » -
News
From equivalent and biosimilars valuable resources for innovation but possible distorting effects
Accesso alle terapie e sostenibilità: da equivalenti e biosimilari risorse preziose per l’innovazione farmaceutica AIFA Editorial – 23/02/2018 La diffusione…
Leggi »